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Background: Empirical observations have shown that
ozonated  autohemotherapy  markedly  improves  the
symptoms of chronic limb ischemia (muscular pain at
rest, intermittent claudication, etc) in atherosclerotic
patients, but mechanisms of action remain unclear.
Aims: Human endothelial cells (HUVECs) are known
to release nitrogen monoxide (NO)  and  we investi-
gated the biological effects of human ozonated serum
on HUVECs in culture.
Methods: We assessed the relevance of peroxidation,
the  release  of  NO  as  nitrite  and  of  three  classical
cytokines.
Results: The  treatment  of  HUVECs  with  ozonated
serum yields a dose dependent increase of thiobarbi-
turic acid reactive substances (TBARS) and of hydro-
gen peroxide (H2O2) and a decrease of protein thiol
groups (PTG). Concomitantly, in comparison to either
the  control  or  the  oxygenated  sample,  there  is  a
significant  and  steady increase of  nitric oxide (NO)
production; this is markedly enhanced by the addition
of L-arginine (20 m M) and inhibited in the presence of
the NO inhibitor, L-NAME (20 mM). The main mediator
of ozone action is H2O2 as it has been shown either
after its direct measurement or by the addition of 20,
40 and 100 m M. Moreover, during 24 hours incubation
we have investigated the production of endothelin 1
(ET-1),  E-selectin  and  Interleukin  8  (IL-8)  and  it
appears  that  ozonation  enhances  IL-8,  inhibits
E-selectin and hardly modifies ET-1 production.
Conclusions: It  appears that  reinfusion of  ozonated
blood,  by  enhancing  release  of  NO,  may  induce
vasodilation in ischemic areas and reduce hypoxia.
Key  words:  Ozone,  Reactive  oxygen  species,  Hydrogen
peroxide,  Nitric  oxide,  Endothelial  cells,  Endothelin-1,
E-selectin, Interleukin-8
Introduction
Blood vessel tone undergoes a complex regulation by
vasodilators (NO, CO, acetylcoline, adenosine, prosta-
cyclin)  and  vasoconstrictor  factors  such  as  super-
oxide anion, endothelins, tromboxane, angiotensin II
and  noradrenaline.1–3 In  vascular  disorders,  partic-
ularly atherosclerosis, the regulation becomes chaotic
owing  to  the  interference  of  oxidants,  adhesion
molecules, cytokines and growth factors leading to
partial  vessel  occlusion  and  hypoxia.  Chronic limb
ischemia is a progressive disease often observed in
atherosclerosis  and  diabetes  leading  to  necrosis  of
extremities. Conventional therapy is carried out with
infusion  of  prostanoids,  vasodilators  and  antiaggre-
gants  but  there  is  vast  empirical  evidence4 that
reinfusion of autologous blood briefly exposed to a
gas  mixture  composed  of  oxygen-ozone  (O2-O3)  is
similarly, if not more beneficial.
However,  so  far double-blind  randomized clinical
trials  have  not  been  performed  and,  for  the  time
being,  we  considered  it  worthwhile  to  investigate
whether human ozonated plasma elicits any effects
on human umbilical vein endothelial cells (HUVECs)
in culture that may help to understand the supposed
therapeutic effect. The present data show that reac-
tive  oxygen  species  (ROS)  and/or  lipid  oxidation
products (LOP) derived from the interaction of ozone
with plasma5 enhance the production of nitric oxide
(NO), interleukin-8 (IL-8) while the release of either
E-selectin or endothelin-1 (ET-1) is either inhibited or
hardly modified, respectively.
Materials and methods
Materials
Analytical grade H2O2 30% was purchased from Fluka
GmbH,  Switzerland.  L-Arginine,  the  NO  synthase
inhibitor  NG-nitro-L-arginine  methyl  ester  (L-NAME)
and  all  the  materials  not  specified  below  were
purchased from Sigma Aldrich srl, Milano, Italy.
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O3 was  produced  from  medical  grade  O2 using
electrical  corona  arc  discharge  with  a  modern  O3
generator  (Model  Ozonosan  PM  100K,  Hansler
GmbH,  Iffezheim,  Germany)  which  allows  the  gas
flow rate and O3 concentration to be controlled in
real time by photometric determination at 253.7 nm
as recommended by the Standardization Committee
of  the International Ozone Association. Tygon poly-
mer tubing and glass syringes were used throughout
the reaction procedure to ensure containment of O3
and consistency in concentration.
Ozone delivery to biological samples
A  predetermined  volume  of  O2/O3 gas  mixture  at
various  O3 concentrations  within  the  therapeutic
range  (20–80mg/ml  of  gas  perml  of  serum)  was
collected with a glass syringe and immediately intro-
duced into a second glass syringe, via a ‘Y’ connector,
containing an identical volume of a pool of human
serum (obtained from the Siena Clinical Blood Cen-
ter).  The  final  gas  pressure  remained  at  normal
atmospheric pressure. In order to obtain reproducible
results it needs to be emphasized that O3 is a very
reactive gas so rapid and precise handling is required.
Samples were gently but continuously mixed with the
gas for 20min and afterwards dispensed either into
test  tubes  for  analyses  or  added  to  cell  cultures.
Control samples were mixed with an equal volume of
O2. It is worth mentioning that O2 represents at least
96% of the O2-O3 mixture.
Culture of Human Umbilical Vein Endothelial
Cells (HUVECs)
Primary  endothelial  cells  were  obtained  from  the
neonatal umbilical cord vein according to Jaffe et al.6
The  main  vein  of  umbilical  cords (kindly  provided
by the nursery of ‘Le Scotte’ hospital of Siena) was
thoroughly  washed  with  PBS  and  then  incubated
with 10ml collagenase (0.2  % dissolved in Medium
199)  from  Clostridium  histiolyticum (type  XI,
Sigma) for 20–25min at 37°C. The endothelial cells
layer  was  removed  from  the  vein  using  50ml  of
Hanks buffer (Sigma). The cells were sedimented at
250´ g for  10min  and  washed  once  with  20ml  of
Medium  199  with  20%  FCS  (Seromed),  and  resus-
pended in 5ml of fresh medium. Cells were grown
in Medium 199, pH 7.4 (Gibco BRL, Rockville, MD)
supplemented  with  20%  FCS,  2mM  glutamine,
10mM Hepes, 100mg/ml heparin, streptomycin-pen-
icillin  and  100mg/ml  of  endothelial  cell  growth
factor  (ECGF).  For  subculture,  the  cells  were  har-
vested with 0.01% EDTA-0.1%  trypsin.
HUVECs were utilized for experiments at 90–95%
(3–3.5´ 106 cell/well)  apparent  confluence  within
passage  3  and  through  6.  Passage were  performed
according to standardized protocols and by diluting
the cell population 1:3.
Cell treatment
The cells were pelleted by centrifugation and seeded
in 6 well plates pre-treated with 1.5% gelatin (type B
from  bovine  skin).  To  each  well  2ml  of  M199
supplemented  with  1%  FCS,  without  heparin  and
ECGF  was  added  for  24h.  The  day  after  cells
confluence  was  around  90–95  %  (3–3.5´ 106 cell/
well). The cells were washed once in Hank’s balanced
salt solution. Ozonated serum (2ml) was added to the
cells  but  after  20min  incubation  the  serum  was
collected for biological determination and the cells
were grown as described above, but without phenol
red in the medium.
Determinations
Hydrogen peroxide (H2O2)  was measured in serum
before and after addition of oxygen and ozone by the
enzymatic  method  described  by  Green  and  Hill.7
Protein thiol groups (PTG) were measured in serum
according to Hu8 using procedure 1 with 5,5’-dithio-
bis(2-nitrobenzoic acid) (DTNB) dissolved in absolute
methanol. The  thiobarbituric  acid  (TBA)  assay  was
carried out in serum as described by Buege and Aust.9
Values are expressed asmM of TBA reactive substances
(TBARS)  relative to a malondialdehyde standard. By
collecting samples at different incubation times (from
2 to 48h), NO production was assayed by determin-
ing  the  increase  in  nitrite  concentration  using  the
classical Griess reaction.10 Cytokines such as IL-8, ET-
1 and E-selectin present in centrifuged tissue cultured
fluids, were kept at –80°C until determinations were
carried  out  by  immunoassay  using  standard  kits
purchased  from  R&D  Systems  (GmbH, Wiesbaden,
Germany). Duplicate samples were diluted 1:1 with
the  appropriate  diluent  and  a  3-cycle  automatic
washing process was routinely performed.
Statistical analyses
All statistical analyses were performed using one-way
analysis of variance (ANOVA) with the Scheff´ e multi-
range  test. All  values  are  expressed  as  Means  and
Standard Deviation (±SD). P values less than either
0.05  or  0.01  were  considered  significant  and  are
marked with 1 or 2 asterisks, respectively.
Results
Initially  we  investigated  whether  ozonated  human
serum  added  to  HUVECs  modifies  NO  production.
Figure 1 shows that the exposure of serum for 1min
to two different concentrations (40 and 80mg/ml of
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reduction of PTG levels while TBARS and H2O2 levels
increase.  Both  control  serum  (untreated)  or  O2
exposed samples show neither modification of TBARS
and PTG values, nor any production of H2O2. HUVECs
incubated with O2-O3 treated serum samples show an
increase of NO production measured as nitrite, that
becomes significant (P<0.05) after 24 and 48h and is
O3 dose dependent. Nitrite levels were not modified
during the first 6h of incubation.
Following this we checked if NO release could be
influenced by the addition of the substrate L-arginine,
or by the inhibitor L-NAME (Fig. 2). L-arginine on its
own markedly (P<0.05) increases NO release in both
control and O2-serum treated HUVECs but NO pro-
duction  is  significantly  higher  when  cultures  are
added with ozonated serum samples, particularly at
ozone  concentration  of  80mg/ml. The  presence  of
L-NAME inhibits NO release in all cases.
Figure1 shows that ozonation of serum is accom-
panied by H2O2 production confirming Pryor’s reac-
tion11 and  our  previous  data.12 Thus  it  would  be
interesting to evaluate if H2O2is able to influence NO
release. Figure 3 shows that there is an almost linear
increase  between  NO  release  and  progressively
higher amounts (20, 40 and 100mM) of H2O2added to
HUVECs.  Moreover  addition  of  L-arginine  strongly
reinforced NO production while L-NAME inhibited to
a great extent, but not entirely, its production.
H2O2is  now  considered  a  crucial  trigger  of  NF-
kB13,14 and it appeared obvious to examine whether
O3-H2O2 induces release of  a few  typical  cytokines
such as ET-1 (Fig. 4), E-selectin (Fig. 5) and IL-8 (Fig.
6). Ozone at both concentrations (40 and 80mg/ml)
significantly enhances the release of IL-8 after 4, 6 and
24  hours  incubation  with  and  without  addition  of
L-arginine confirming the ability of ozone to induce
IL-8 production in blood15,16 and respiratory epithe-
lial cells.17 Release of E-selectin or ET-1 appears either
depressed or practically unmodified.
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FIG.  1.  Effect  of  different  concentrations of  ozone  on  the
production of nitrite by HUVECs, 24 and 48h after addition of
ozonated human serum (top panel). Effect of either oxygen
or ozone on PTG, TBARS and H2O2 levels in the serum before
addition to HUVECs. The data are presented as the arithmetic
mean ±SD of 6 different experiments.
FIG. 2. Production of nitrite by HUVECs, measured after 24h
incubation,  after  addition  of  normal  human  serum  either
oxygenated  or  ozonated  (at  40  and  80mg/ml).  Effects  of
addition of L-arginine and L-NAME. The data are presented
as the arithmetic mean ±SD of 6 different experiments.
FIG. 3. Production of NO by HUVECs, measured after 24h
incubation,  after  addition  of  three  concentration of  H2O2.
Effects of the addition of L-arginine and L-NAME. The data
are  presented  as  the  arithmetic mean  ±SD  of  6  different
experiments.Discussion
Vascular disorders caused by  atherosclerosis, diabe-
tes and smoking at the level of the brain, heart and
limbs represent a formidable social-economical prob-
lem affecting several millions of people worldwide.
Orthodox  medicine  uses  a  variety  of  approaches
such  as  surgery,  anticoagulants,  trombolytic  com-
pounds,  vasodilators  antioxidants  and  now  even
gene  therapy18 for  normalizing  damaged  vessels,
reducing  restenosis and  minimising  damage  follow-
ing  severe  ischemia.  During  the  last  decade  our
laboratory  has  been  involved  in  clarifying  mecha-
nisms of action triggered by ozone when this gas is
briefly  mixed  with  human  blood.4 Like  oxygen,
ozone  dissolves  in  the  plasma  and  reacts  quickly
with a number of substrates such as polyunsaturated
fatty  acids  (PUFA),  -SH  groups  present  in  several
compounds  and  antioxidants.11 An  array  of  gen-
erated  products  namely  H2O2,  malondialdehyde,
4-hydroxynonenal,  hydroperoxides  and  lipoperox-
ides19 may act as cellular signals and trigger biolog-
ical effects. It must  be  said that these compounds,
depending on their concentrations, seem to behave
as a double-edged sword.20 For this reason we have
been  very  careful  in  defining  the  biological  active
dose that, in  terms of  ozone concentration, ranges
between  20  and  80mg/ml  gas  perml  of  blood
without displaying toxic effects neither in vitro nor
in vivo.4,21 Empirical observations have shown that
ozone  enhances  delivery  of  oxygen  to  hypoxic
tissue  and  we  have  hypothesized  that  ozonated
plasma during reinfusion may elicit some effects on
the  vessel  wall  possibly  enhancing  vasodilatation.
Indeed the present results give credence to this idea
by showing an enhanced production of NO, which
is an important component of the negative feed-back
loop  that  prevents  thrombogenesis. The  adherence
of platelets to the vessel wall, and their aggregation,
is suppressed by nitrovasodilators capable of increas-
ing  the  intracellular  cGMP,  with  consequent  phos-
phorylation  of  cGMP-dependent  phosphoproteins
and  suppression  of  platelet  reactivity.22 The  pos-
sible  formation in  vivo of  nitrosocompounds, with
longer  lifetime  than  NO,  may  slowly  decrease  the
vasospasm.
Our data showing inhibition of release of E-selectin,
especially after 2 and 6 hours, and no increase of ET-1.
This is consistent with previous reports23–26 showing
a reciprocal regulation of the expression of ET-1 and
endothelial cell adhesion molecules in comparison to
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FIG. 4. Kinetic of release of endothelin-1 from HUVECs after
addition of human serum either after oxygenation or after
ozonation. Effect of the addition of L-arginine and L-NAME.
The data are presented as  the arithmetic mean  ±SD  of  6
different experiments.
FIG. 5. Kinetics of release of E-selectin from HUVECs after
addition of human serum either after oxygenation or after
ozonation. Effect of the addition of L-arginine and L-NAME.
The data are presented as  the arithmetic mean  ±SD  of  6
different experiments.production of NO. At present, we cannot say whether
ozonated serum is able to increase gene expression of
VEGF,27 that  is  whether  a  potent  mitogen  that  by
stimulating neoangiogenesis may be helpful in coro-
nary and critical leg ischemia. This is a very important
point  that  unfortunately  has  not  been  clarified.
However Chua et al.28 have clearly shown that VEGF
mRNA was expressed in a dose- and time-dependent
manner  when  rat  heart  endothelial  cells  were
exposed to 0.5–1mM H2O2.
In  conclusion  we  have  shown  for  the  first  time
that  human  serum  briefly  exposed  to  biologically
active  and atoxic  ozone concentration (from  20  to
80mg/ml perml of plasma) after a 20min incubation
with  HUVECs  induces  H2O2 production  (up  to
40mM).  This  concentration  is  possibly  underesti-
mated because it has been observed12 that the mean
half-life of H2O2 in plasma is about 2min. Addition of
H2O2 to HUVECs, in turn, as we have now shown,
induces  a  dose-dependent  increase  of  NO  further
enhanced by L-arginine. It must be emphasized that
HUVECs were kept in contact with ozonated serum
for  only  20min.  This  approximately  corresponds
to  the  period  of  time  of  blood  reinfusion.  So  far
we  have  not  addressed  the  issue  of  whether  NO
production  is  due  to  constitutively  present  NO-
synthase  (Ca++ dependent), typical  of  the endothe-
lium,  or  the  newly  induced  enzyme  (iNOS,  Ca++
independent) which seems most likely as at 2, 4 and
6  hours after treatment we could not measure any
nitrite  increase.  However  work  in  progress  will
clarify this question and elucidate whether ozonated
plasma added to HUVECs, simulating the reinfusion
of  ozonated  blood  in  patients,  is  able  to  induce
neoangiogenesis.
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